What is the highest clinical development phase achieved by ablysinol in the united states?

What phase has ablysinol reached in U.S. clinical development?

Ablysinol has reached Phase 2 clinical development in the United States. [1]

Where does that place ablysinol compared with later-stage programs?

Reaching Phase 2 means ablysinol has moved beyond early safety/tolerability testing (Phase 1) and is being studied for efficacy and further safety in a larger group of patients, but it has not yet reached Phase 3 in the U.S. based on the available development record. [1]

Source

[1] https://www.drugpatentwatch.com/p/ablysinol